Accelerating FemTech (Health Innovation Network / Innovate UK)

Amount

Free

Biomedical Catalyst access

Deadline

Rolling

Odds

~10–21 per cohort

Effort

10 minutes

Can you get this?

✓UK-based SMEs, spinouts, or academics eligible

✓Focus on women's health innovation required

✓Early-stage innovations supported (cohorts 1–3)

✓Later-stage strand requires TRL 4 or above

Your real odds

Three cohorts have run since 2023, accepting 43 companies in total, roughly 10 to 21 per cohort.

Of those 43 companies, 25 went on to receive feasibility funding through a closed-call Biomedical Catalyst opportunity. The programme has run repeatedly, which suggests Innovate UK continues to commission it.

What it takes

Check the funder's site for the next open cohort10 minutes

Prepare a clear pitch on your women's health innovation and commercial stage1–2 days

Submit application when the call opensVaries by cohort

Worth knowing

Acceptance gets you into a closed-call Innovate UK Biomedical Catalyst funding opportunity that the general public cannot access, and 25 of the 43 cohort companies have won feasibility funding through it, so the accelerator itself is a real route into Innovate UK money.

Apply on funder's site →

What else do you qualify for?

Filter 1,700+ opportunities by identity, stage, and region.

Identity

Stage

Region

Select all three to see your result.

This is 1 of 1,600+ open opportunities.

$50B+ in available capital across grants, VC funds, CDFIs, and accelerators. Filter by your industry, stage, and region, and see everything you qualify for.

Explore the funding database →

$19/month · cancel anytime